Tearsheet

Addus HomeCare (ADUS)


Market Price (12/17/2025): $113.71 | Market Cap: $2.1 Bil
Sector: Health Care | Industry: Health Care Services

Addus HomeCare (ADUS)


Market Price (12/17/2025): $113.71
Market Cap: $2.1 Bil
Sector: Health Care
Industry: Health Care Services

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow


0 Low stock price volatility
Vol 12M is 32%
Weak multi-year price returns
2Y Excs Rtn is -26%, 3Y Excs Rtn is -61%
Key risks
ADUS key risks include [1] the potential failure to successfully integrate acquisitions and achieve anticipated synergies from its M&A-focused growth strategy.
1 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Remote Patient Monitoring, Show more.
  
0 Low stock price volatility
Vol 12M is 32%
1 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Remote Patient Monitoring, Show more.
2 Weak multi-year price returns
2Y Excs Rtn is -26%, 3Y Excs Rtn is -61%
3 Key risks
ADUS key risks include [1] the potential failure to successfully integrate acquisitions and achieve anticipated synergies from its M&A-focused growth strategy.

Valuation, Metrics & Events

ADUS Stock


Why The Stock Moved


Qualitative Assessment

AI Generated Analysis | Feedback

The information available indicates financial results for Addus HomeCare (ADUS) during parts of 2025. Specifically, second-quarter 2025 financial results were announced on August 4, 2025, and third-quarter 2025 financial results were announced on November 3, 2025. Fourth-quarter and year-end 2024 results were announced on February 24, 2025, providing a view into the start of 2025. There are also mentions of analyst ratings and price targets updated as recently as November 13, 2025. However, the request asks for key points explaining a specific -1.9% stock movement for the period from August 31, 2025, to December 18, 2025. While there's information around this period, a precise stock movement of -1.9% and its direct causes for this specific future-facing window are not explicitly detailed in the search results. The available information primarily covers earnings reports and general company performance, which show growth rather than a decline for the quarters reported in 2025. It is not possible to identify the exact reasons for a precisely -1.9% stock movement within the specified timeframe from the provided search results. The financial reports released during this period generally show positive growth in revenues and adjusted EBITDA for Q2 and Q3 2025. Given that the direct explanation for a -1.9% stock movement within the specified future-facing period is not explicitly available, it is not possible to provide the requested five key points.

Show more

Stock Movement Drivers

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
ADUS Return20%-20%6%-7%35%-9%17%
Peers Return49%
S&P 500 Return16%27%-19%24%23%14%108%

Monthly Win Rates [3]
ADUS Win Rate58%33%50%50%67%58% 
Peers Win Rate56%58% 
S&P 500 Win Rate58%75%42%67%75%73% 

Max Drawdowns [4]
ADUS Max Drawdown-50%-37%-25%-21%-7%-28% 
Peers Max Drawdown-15% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: EHAB, ENSG, AVAH, CHE, BTSG. See ADUS Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/17/2025 (YTD)

How Low Can It Go

Unique KeyEventADUSS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-44.9%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven81.5%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven902 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-53.4%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven114.5%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven219 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-23.1%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven30.0%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven154 days120 days

Compare to BTSG, BKD, VRDN, USPH, CVS


In The Past

Addus HomeCare's stock fell -44.9% during the 2022 Inflation Shock from a high on 1/22/2021. A -44.9% loss requires a 81.5% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Addus HomeCare (ADUS)

Better Bets than Addus HomeCare (ADUS)

Trade Ideas

Select past ideas related to ADUS. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
16.3%16.3%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-7.1%-7.1%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
3.6%3.6%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
1.6%1.6%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
14.1%14.1%-5.1%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
16.3%16.3%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-7.1%-7.1%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
3.6%3.6%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
1.6%1.6%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
14.1%14.1%-5.1%

Recent Active Movers

Recent Active Movers

More From Trefis

Peer Comparisons for Addus HomeCare

Peers to compare with:

Financials

ADUSEHABENSGAVAHCHEBTSGMedian
NameAddus Ho.Enhabit Ensign Aveanna .Chemed BrightSp. 
Mkt Price113.129.62176.618.93431.0535.5874.35
Mkt Cap2.00.510.11.96.27.24.1
Rev LTM1,3471,0484,8292,2912,53113,3012,411
Op Inc LTM12362402235352341288
FCF LTM9658498336027689
FCF 3Y Avg10752132223115581
CFO LTM1036248190420349226
CFO 3Y Avg1155738530368132124

Growth & Margins

ADUSEHABENSGAVAHCHEBTSGMedian
NameAddus Ho.Enhabit Ensign Aveanna .Chemed BrightSp. 
Rev Chg LTM18.8%1.0%17.5%15.5%6.5%37.1%16.5%
Rev Chg 3Y Avg13.3%-1.1%18.4%9.5%5.9%24.3%11.4%
Rev Chg Q25.0%3.9%19.8%22.2%3.1%28.2%21.0%
QoQ Delta Rev Chg LTM5.7%1.0%4.7%5.2%0.7%5.8%4.9%
Op Mgn LTM9.2%5.9%8.3%10.3%13.9%2.6%8.7%
Op Mgn 3Y Avg8.8%4.8%7.9%7.0%14.5%1.8%7.5%
QoQ Delta Op Mgn LTM0.0%0.6%-0.2%0.3%-0.8%0.3%0.2%
CFO/Rev LTM7.7%5.9%10.0%3.9%16.6%2.6%6.8%
CFO/Rev 3Y Avg10.0%5.4%9.2%1.3%15.4%1.0%7.3%
FCF/Rev LTM7.2%5.5%1.0%3.6%14.2%2.1%4.6%
FCF/Rev 3Y Avg9.2%5.0%3.4%0.9%13.0%0.3%4.2%

Valuation

ADUSEHABENSGAVAHCHEBTSGMedian
NameAddus Ho.Enhabit Ensign Aveanna .Chemed BrightSp. 
Mkt Cap2.00.510.11.96.27.24.1
P/S1.60.42.10.82.50.51.2
P/EBIT16.914.822.67.817.317.617.1
P/E24.9-34.130.224.523.146.424.7
P/CFO20.76.520.620.715.417.218.9
Total Yield4.0%-2.9%3.5%4.1%4.7%2.2%3.7%
Dividend Yield0.0%0.0%0.1%0.0%0.4%0.0%0.0%
FCF Yield 3Y Avg5.6%12.0%2.1%-1.9%4.1%-4.1%
D/E0.11.30.20.70.00.40.3
Net D/E0.01.10.20.60.00.40.3

Returns

ADUSEHABENSGAVAHCHEBTSGMedian
NameAddus Ho.Enhabit Ensign Aveanna .Chemed BrightSp. 
1M Rtn4.9%20.4%-0.5%4.2%-0.3%13.5%4.6%
3M Rtn4.6%24.6%6.5%10.5%-5.6%29.9%8.5%
6M Rtn-1.8%3.0%13.0%86.4%-20.8%59.0%8.0%
12M Rtn-13.5%16.0%26.4%86.8%-17.5%92.7%21.2%
3Y Rtn10.3%-28.5%85.7%994.0%-13.4%-10.3%
1M Excs Rtn4.2%19.7%-1.3%3.5%-1.0%12.7%3.8%
3M Excs Rtn1.7%18.0%4.4%4.2%-7.2%29.2%4.3%
6M Excs Rtn-14.2%-9.4%0.7%74.1%-33.2%46.6%-4.4%
12M Excs Rtn-20.6%1.8%13.1%66.5%-31.9%80.6%7.5%
3Y Excs Rtn-61.1%-99.6%22.7%856.9%-83.8%--61.1%

Financials

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Personal Care795707686647581
Hospice20720215210154
Home Health5743261614
Total1,059951864765649


Operating Income by Segment
$ Mil20242023202220212020
Personal Care15812512210791
Hospice4551422914
Home Health73311
Depreciation and amortization-14-14-14-12-11
Other general and administrative expenses-104-96-88-80-61
Total9169664535


Price Behavior

Short Interest

Short Interest: As Of Date11282025
Short Interest: Shares Quantity720,211
Short Interest: % Change Since 111520256.1%
Average Daily Volume179,904
Days-to-Cover Short Interest4
Basic Shares Quantity18,072,000
Short % of Basic Shares4.0%

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
11/3/2025-5.7%-5.2%-4.1%
8/4/20259.0%4.7%5.7%
5/5/20254.1%5.9%7.3%
2/24/2025-10.4%-12.7%-12.7%
11/4/2024-3.7%-0.8%-4.2%
8/5/20245.8%6.6%10.9%
5/6/20246.8%13.0%17.2%
2/26/20245.5%9.6%17.4%
...
SUMMARY STATS   
# Positive131210
# Negative7810
Median Positive5.8%6.8%7.5%
Median Negative-5.2%-5.3%-6.0%
Max Positive12.9%13.0%17.4%
Max Negative-14.8%-17.9%-25.4%

SEC Filings

Expand for More

Report DateFiling DateFiling
93020251104202510-Q 9/30/2025
6302025805202510-Q 6/30/2025
3312025506202510-Q 3/31/2025
12312024225202510-K 12/31/2024
93020241105202410-Q 9/30/2024
6302024806202410-Q 6/30/2024
3312024507202410-Q 3/31/2024
12312023227202410-K 12/31/2023
93020231031202310-Q 9/30/2023
6302023801202310-Q 6/30/2023
3312023502202310-Q 3/31/2023
12312022228202310-K 12/31/2022
93020221101202210-Q 9/30/2022
6302022802202210-Q 6/30/2022
3312022503202210-Q 3/31/2022
12312021225202210-K 12/31/2021